CTOs on the Move

Alkeus Pharmaceuticals, Inc.

www.alkeuspharma.com

 
Alkeus Pharmaceuticals, Inc. is a late-stage biopharmaceutical company developing transformative therapeutics to address serious, progressive eye diseases that lead to blindness. Our lead compound, ALK-001, is an oral investigational drug being developed for the treatment of Stargardt disease (STGD) and Geographic Atrophy (GA) secondary to dry age-related macular degeneration. ALK-001 is a selectively-deuterated form of Vitamin A that slows the dimerization of Vitamin A, which is implicated in STGD, and has shown statistically-significant and clinically-meaningful efficacy in the TEASE-1 Phase 2 clinical trial. Based on these results, ALK-001 has been granted Breakthrough Therapy Designation for the treatment of Stargardt Disease.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Tower Technologies Inc

Tower Technologies Inc is a Annapolis, MD-based company in the Business Services sector.

ZUMA Press

ZUMA Press is a San Clemente, CA-based company in the Business Services sector.

Express Mold

Express Mold is a Libertyville, IL-based company in the Business Services sector.

Capital Area Food Bank

The Capital Area Food Bank is the largest organization in the Washington metro area working to solve hunger and its companion problems: chronic undernutrition, heart disease, diabetes, and obesity.